Liver Cancer News
2026
February
Transplant Oncology Expands Liver Transplant Options
Biosimilar-Backed Triplet Regimen Shows Feasibility in Heavily Pretreated Liver Cancer
Pressure-Driven Pathway Links Liver Congestion to Fibrosis and Cancer
Biomarkers Indicating Higher Liver Cancer Risk In Chronic Hepatitis B Patients Identified
Evaluating The Clinical Utility Of MRI In Liver Cancer Planning And Simulation
iMBIs Support Patients With HCC, But Resistance to Mindfulness Practice May Persist
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
PLT012 Receives FDA Fast Track Designation for Liver Cancer Treatment
'I Thought I Had Indigestion - It Turned Out To Be Liver Cancer'
Machine-Learned Biomarker Identifies Those At High Risk For Liver Cancer
Researchers Develop New Score To Predict The Risk Of Liver Cancer
'Right Side' Symptom Could Be Sign Of 'Silent Killer' Cancer According To NHS
A Liver Cancer Journey Marked by Persistence, Family and Hope
FDA Fast Track Designation Highlights New Option in Advanced Liver Cancer
Plasma Cell-Free DNA Methylation Analysis Is Highly Sensitive to Detecting Hepatocellular Carcinoma
From Missed Signs to Second Chances After a Liver Cancer Diagnosis
A Simple Diet Change Could Slow Liver Cancer
Liver Cancer Rates Start to Decline but Survival Gains Stalled During COVID
Abbreviated Hepatocellular Carcinoma MRI Protocols Have Many Benefits
Never Ignore These 12 Symptoms, Your Body Could Be Warning Of Liver Cancer
Key Oncology Drugs Granted FDA Designations in January 2026
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
January
Restricting Dietary Protein Could Prevent Liver Cancer Development in At-Risk Patients
How a Simple Dietary Change May Slow Liver Cancer in At-Risk Patients
Third NDA for Rivoceranib/Camrelizumab Is Resubmitted to FDA for Unresectable HCC
Scientists Discover Potential New Cancer Treatment
HCC: LLM Advice and Treatment Concordance
AI Treatment Suggestions for Liver Cancer More Accurate at Early Stages
Atezolizumab Combo May Be Superior to TACE for Certain Liver Cancers
A Natural “Safety Switch” Protects the Liver as it Heals from Injury, Study Finds
Scientists Warn Of Hidden Cancer Risk In Popular Fatty Liver Treatment Strategy
Adjuvant Pembrolizumab Fails in Phase 3 Liver Cancer Trial
Atezolizumab Plus Bevacizumab Shows Potential Advantage Over TACE in Intermediate-Stage HCC
Your Liver May Already Be Changing Because Of What You Eat Every Day, Scientists Warn
Breaking Down Key Misconceptions in Hepatocellular Carcinoma Care
Ablation Success Rate for Liver Cancer. What Patients Need to Know in 2026
For past liver cancer news, please visit our Liver Cancer News Archives.